Showing results (31-40 of 114) with videos related to

Sort By:
Pageof 12
Biochimica Et Biophysica Acta|May 22, 2003
Recombinant human C1-inhibitor produced in Pichia pastoris has the same inhibitory capacity as plasma C1-inhibitorIneke G A Bos, Eric C de Bruin, Yani A Karuntu, et al.
Cell Death and Differentiation|January 26, 2021
Regulation of Bcl-XL by non-canonical NF-κB in the context of CD40-induced drug resistance in CLLMarco Haselager, Rachel Thijssen, Christopher West, et al.
Blood|September 18, 2008
c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant nichesDelfine Y H Hallaert, Annelieke Jaspers, Carel J van Noesel, et al.
Haematologica|July 13, 2023
Electron transport chain and mTOR inhibition synergistically decrease CD40 signaling and counteract venetoclax resistance in chronic lymphocytic leukemiaZhenghao Chen, Gaspard Cretenet, Valeria Carnazzo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 13, 2019
Dissection of the Effects of JAK and BTK Inhibitors on the Functionality of Healthy and Malignant LymphocytesTom Hofland, Iris de Weerdt, Hanneke Ter Burg, et al.
British Journal of Haematology|August 4, 2004
Autologous cytomegalovirus-specific T cells as effector cells in immunotherapy of B cell chronic lymphocytic leukaemiaArnon P Kater, Ester B M Remmerswaal, Martijn A Nolte, et al.
International Immunology|June 6, 2007
CD27-CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell developmentMichiel F van Oosterwijk, Hedi Juwana, Ramon Arens, et al.
Biochemical and Biophysical Research Communications|December 28, 2010
WNT signaling controls expression of pro-apoptotic BOK and BAX in intestinal cancerJurrit Zeilstra, Sander P J Joosten, Felix M Wensveen, et al.
Blood|January 27, 2012
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemiaMartin F M de Rooij, Annemieke Kuil, Christian R Geest, et al.
Molecular Oncology|December 23, 2022
JAK-STAT signalling shapes the NF-κB response in CLL towards venetoclax sensitivity or resistance via Bcl-XLMarco V Haselager, Rachel Thijssen, Danique Bax, et al.
Pageof 12